These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 9331138)
1. A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer. Birch R; Weaver CH; Hainsworth JD; Bobo C; Greco FA Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-135-S12-137. PubMed ID: 9331138 [TBL] [Abstract][Full Text] [Related]
2. Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer. Greco FA; Hainsworth JD Semin Oncol; 1996 Dec; 23(6 Suppl 16):7-10. PubMed ID: 9007113 [TBL] [Abstract][Full Text] [Related]
3. Carboplatin/etoposide/radiation plus escalating doses of paclitaxel in stage III non-small cell lung cancer: a preliminary report. Bonomi P; Faber LP; Recine D; Lincoln S Semin Oncol; 1995 Aug; 22(4 Suppl 9):42-7. PubMed ID: 7644927 [TBL] [Abstract][Full Text] [Related]
4. A phase II study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer. Neill HB; Miller AA; Clamon GH; Perry MC; Crawford J; Green MR Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-130-S12-134. PubMed ID: 9331137 [TBL] [Abstract][Full Text] [Related]
5. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy. Hainsworth JD; Greco FA Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970 [TBL] [Abstract][Full Text] [Related]
6. Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial. Greco FA; Thompson DS; Morrissey LH; Erland JB; Burris HA; Spigel DR; Joseph G; Corso SW; Spremulli E; Hainsworth JD Oncologist; 2005 Oct; 10(9):728-33. PubMed ID: 16249353 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized study. Kosmidis P; Mylonakis N; Fountzilas G; Samantas E; Athanassiadis A; Pavlidis N; Skarlos D Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-30-S12-33. PubMed ID: 9331117 [TBL] [Abstract][Full Text] [Related]
9. Paclitaxel, carboplatin, and oral etoposide: a phase II trial in limited-stage small cell lung cancer. Gatzemeier U; Jagos U; Kaukel E; Koschel G; von Pawel J Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-149-S12-152. PubMed ID: 9331141 [TBL] [Abstract][Full Text] [Related]
10. Postoperative bronchopulmonary complications in stage III lung cancer patients treated with preoperative paclitaxel-containing chemotherapy and concurrent radiation. Bonomi P; Faber LP; Warren W; Lincoln S; LaFollette S; Sharma M; Recine D Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-123-S12-129. PubMed ID: 9331136 [TBL] [Abstract][Full Text] [Related]
11. Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials. DeVore RF; Jagasia M; Johnson DH Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-27-S12-29. PubMed ID: 9331116 [TBL] [Abstract][Full Text] [Related]
12. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer: a University of Colorado Cancer Center study. Bunn PA; Kelly KL Semin Oncol; 1995 Oct; 22(5 Suppl 12):54-8; discussion 59-60. PubMed ID: 7481862 [TBL] [Abstract][Full Text] [Related]
13. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer. Bunn PA; Kelly K Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-144-S12-148. PubMed ID: 9331140 [TBL] [Abstract][Full Text] [Related]
14. One-hour paclitaxel in the treatment of non-small cell lung cancer. Hainsworth JD; Greco FA Semin Oncol; 1996 Dec; 23(6 Suppl 16):98-101. PubMed ID: 9007133 [TBL] [Abstract][Full Text] [Related]
15. Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713. Edelman MJ; Chansky K; Gaspar LE; Leigh B; Weiss GR; Taylor SA; Crowley J; Livingston R; Gandara DR J Clin Oncol; 2004 Jan; 22(1):127-32. PubMed ID: 14701775 [TBL] [Abstract][Full Text] [Related]
16. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer. Strauss GM; Lynch TJ; Elias AD; Jacobs C; Kwiatkowski DJ; Shulman LN; Carey RW; Grossbard ML; Jauss S; Sugarbaker DJ Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma. Hainsworth JD; Stroup SL; Greco FA Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693 [TBL] [Abstract][Full Text] [Related]
18. Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial. Socinski MA; Clark JA; Halle J; Steagall A; Kaluzny B; Rosenman JG Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-117-S12-122. PubMed ID: 9331135 [TBL] [Abstract][Full Text] [Related]
19. Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer. German AGO Study Group Ovarian Cancer. Arbeitsgemeinschaft Gynäkologische Onkologie. du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Bauknecht T; Warm M; Schroeder W; Olbricht S; Nitz U; Jackisch C Semin Oncol; 1997 Aug; 24(4 Suppl 11):S11-28-S11-33. PubMed ID: 9314296 [TBL] [Abstract][Full Text] [Related]
20. Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study. Porter D; Boddy A; Thomas H; Lind M; Newell D; Calvert AH; Robson L; Brampton M; Abrahamsen D; Winograd B Semin Oncol; 1996 Dec; 23(6 Suppl 13):34-44. PubMed ID: 8996574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]